Status:
COMPLETED
Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Neuralgia
Spinal Cord Injuries
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to provide critical information about the efficacy of Immersive Virtual Reality (IVR) to decrease the experience of neuropathic pain in the upper and lower extremities of peop...
Detailed Description
When a spinal cord injury occurs, the spinal somatosensory circuit is thought to generate aberrant nociceptive impulses that the brain interprets as pain. Neuropathic pain (NP) affects 40 to 70% of pe...
Eligibility Criteria
Inclusion
- Spinal cord injury survivors (chronic only)
- Presence of neuropathic pain at or below SCI level for at least 6 months following trauma or disease of the spinal cord
- A pain intensity of at least 2 out of 10 in the numerical pain rating scale (NPRS) test at baseline
- Stable pharmacological treatment for at least 4 weeks prior to the study and throughout the trial
Exclusion
- Psychiatric or other neurological disorders (Participants will not be excluded for having a SCI, if they score 0-30 points on the BDI, or if they report having anxiety)
- Head injuries causing cognitive or visual impairment
- Severe vertigo
Key Trial Info
Start Date :
July 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2022
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04700033
Start Date
July 17 2019
End Date
May 5 2022
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029